HOTH THERAPEUTICS INC (HOTH)

US44148G2049 - Common Stock

1.6  +0.01 (+0.63%)

News Image
18 days ago - Hoth Therapeutics, Inc.

Hoth Therapeutics and Algorithm Sciences Terminate Letter of Intent to Merge

/PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient focused biopharmaceutical company, today announced that they have entered into a mutual...

News Image
a month ago - Moore Kuehn, PLLC

Moore Kuehn Encourages HOTH, HSKA, SPPI, and GLOP Investors to Contact Law Firm

/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...

News Image
a month ago - Halper Sadeh LLP

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SGEN, SPPI, HOTH

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

News Image
a month ago - Hoth Therapeutics, Inc.

Hoth Therapeutics and Algorithm Sciences Execute Letter of Intent to Merge

/PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient focused biopharmaceutical company, today announced it has signed a Letter of Intent to merge...

News Image
3 months ago - Hoth Therapeutics, Inc.

Hoth Therapeutics Announces Collaboration with First Active Clinical Site for its Phase 2 Trial to Treat Cancer Disorders Associated with Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy

/PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced the activation of Washington University...

News Image
3 months ago - Seeking Alpha

HOTH stock jumps on deal to monitor illegal short selling (NASDAQ:HOTH)

Nano-cap pharma Hoth Therapeutics (HOTH) climbed ~26% on Thursday after announcing an agreement wwith ShareIntel to take action against naked short selling. Read the full story here.

News Image
3 months ago - Hoth Therapeutics, Inc.

Hoth Therapeutics Retains ShareIntel to Investigate Illegal Naked Shorting Activity

/PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ:HOTH), a patient-focused biopharmaceutical company, today announced that it has entered into a service...

News Image
4 months ago - Hoth Therapeutics, Inc.

Hoth Therapeutics Announces Increased Positive Results of its Alzheimer's Therapeutic HT-ALZ

/PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ:HOTH), a patient-focused biopharmaceutical company, today announced proof-of-concept data generated using...

News Image
4 months ago - Hoth Therapeutics, Inc.

Hoth Therapeutics Announces Selection of First 3 Clinical Sites for its Phase 2 Clinical Trial to Treat Cancer Disorders Associated with Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy

/PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced that it has selected 3 of its clinical...

News Image
5 months ago - Hoth Therapeutics, Inc.

Hoth Therapeutics Announces Closing of $10 Million Private Placement Priced At-the-Market Under Nasdaq Rules

/PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH) (the "Company" or "Hoth"), a patient-focused biopharmaceutical company, today announced the closing of...

News Image
5 months ago - FinancialNewsMedia

Global Rheumatoid Arthritis Drugs Market Expected To Hit US$ 70 Billion By 2030

EQNX::TICKER_START (NASDAQ:SILO),(NASDAQ:BXRX),(NASDAQ:HOTH),(NASDAQ:KALA),(NASDAQ:NUWE) EQNX::TICKER_END

News Image
5 months ago - FinancialNewsMedia.com

Global Rheumatoid Arthritis Drugs Market Expected To Hit US$ 70 Billion By 2030

/PRNewswire/ -- According to the Centers for Disease Control and Prevention, arthritis affects approximately one in every four Americans, or 58.5 million...

News Image
5 months ago - Seeking Alpha

HOTH stock crashes on $10M private placement (NASDAQ:HOTH)

Hoth Therapeutics (HOTH) lost ~38% to end a two-day rally in the pre-market Friday after announcing a private placement to raise $10M in gross proceeds. Read the full story here.

News Image
5 months ago - Hoth Therapeutics, Inc.

Hoth Therapeutics Announces $10 Million Private Placement Priced At-the-Market Under Nasdaq Rules

/PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced that it has entered into a definitive...